Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Extensive R&D Capabilities：ICP DAS - BMP to Showcase a Broad Range of Medical-Grade TPU at MD&M West 2024, U.S. 2024-01-23 10:06
YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024 2024-01-23 06:00
NK CellTech Announces FDA Clearance for Clinical Trial of NK010 2024-01-22 20:10
Telix Highlights Presentations at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2024) 2024-01-22 19:00
Everest Medicines Announces 2023 Revenue Expected to be Between RMB124 Million and RMB126 Million 2024-01-22 07:50
Sanyou Super Trillion Peptide Molecule Discovery Platform Officially Launched Today 2024-01-20 08:00
Jacobio Pharma Presents Data of Glecirasib in Patients with Pancreatic Cancer and Other Solid Tumors at the 2024 ASCO GI 2024-01-20 06:30
CARsgen's Presents Updated Research Results on CT041 at 2024 ASCO GI Meeting 2024-01-19 21:50
Call for Application for 2024 Tsinghua Amgen Scholars Program 2024-01-19 15:32
Harbour BioMed Announces Positive Profit Alert 2024-01-19 12:52
Top Employer 2024 certification reflects Boehringer Ingelheim's impactful people development in Asia Pacific 2024-01-18 12:00
FDA CLEARANCE OF AMPLIA'S IND FOR PANCREATIC CANCER TRIAL IN US 2024-01-18 10:31
Octapharma to present clinical and scientific data that advances our understanding and treatment of bleeding disorders at the 17th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD), which takes place in Frankfurt, Germany, from February 6 - 9, 2024 2024-01-18 02:20
Adagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC) 2024-01-17 20:00
Olverembatinib Included in Newest Guidelines on Chronic Myeloid Leukemia (CML) Management from the National Comprehensive Cancer Network (NCCN) 2024-01-17 12:10
Epitomee® Announces Successful Completion of Pivotal Clinical Trial for Innovative Weight Loss Capsule 2024-01-16 21:00
Chipscreen NewWay: First Patient Dosed in Phase 1 Trial of the Bispecific Antibody NWY001, a Next-generation Tumor Immunotherapy in Patients with Advanced Solid Tumors 2024-01-16 17:00
CARsgen's CT011 achieves IND clearance from the NMPA for the GPC3-positive stage Ⅲa hepatocellular carcinoma at high risk of recurrence after surgical resection 2024-01-15 21:50
Positive Outcome from a Phase Ib Study in Australia Treating Patients with Androgenic Alopecia 2024-01-15 08:08
Subject Enrollment Completed for International Multicenter Comparative Clinical (Phase 3) Study of Boan Biotech's Denosumab 2024-01-12 21:15
1 55 56 57 58 59 413